Commandité
Biotech Partnerships Accelerate FTD Drug Development
The frontotemporal disorders treatment market, addressing rare but impactful neurodegenerative diseases, is poised for steady growth. Valued at USD 343.8 million in 2022, it is projected to reach USD 451.4 million by 2028, up at a 4.6% CAGR (2022–28). Frontotemporal Disorders Treatment Market  Request a sample copy of the research report:...
0 Commentaires 0 Parts 615 Vue 0 Aperçu
Commandité
Commandité
Commandité